Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016		Sep. 30, 2015
Cash flows from operating activities:
Net income (loss)	$ 61,314		$ (71,901)
Adjustments to reconcile net income (loss) to net cash (used in) operating activities:
Amortization of premium or discount on fixed maturity securities	247		454
Net realized (gain) on sale of investments	(19)		(319)
Unrealized (gain) loss on trading securities	(83)		311
Unrealized (gain) loss on derivative liability - embedded conversion feature	(62,587)		65,917
Equity-based compensation	484		961
Changes in assets and liabilities:
Accrued investment income	(18)		193
Other assets	(270)		17
Cash equivalents held in trust	1,358		5,769
Restricted cash	(1,476)		(579,927)
Losses and loss adjustment reserves	(2,733)		(12,365)
Losses payable	(395)		(550)
Unearned premiums	(463)		(258)
Accrued ceding commission expense	(8)		(8)
Accrued interest on notes payable	(24)		(26)
Loss contract reserve change	(2,362)		(2,783)
Other liabilities	(626)		11,886
Total adjustments	(68,975)		(510,728)
Net cash (used in) operating activities	(7,661)		(582,629)
Cash flows from investing activities:
Purchase of investments	(130,469)		(202,398)
Proceeds from sales and maturities of investments	146,920		156,588
Net cash provided by (used in) investing activities	16,451		(45,810)
Cash flows from financing activities:
Proceeds from issuance of preferred stock			600,000
Fees incurred and paid relating to preferred stock issuance			(19,310)
Redeemable convertible series B preferred stock dividends	(13,500)		(12,498)
Notes payable – principal repayments	(2,185)		(3,330)
Notes payable – principal issued			918
Net cash (used in) provided by financing activities	(15,685)		565,780
(Decrease) in cash and cash equivalents	(6,895)		(62,659)
Cash and cash equivalents, beginning of period	9,924	[1]	78,009
Cash and cash equivalents, end of period	3,029		15,350
Supplementary disclosure of cash flow information:
Cash paid during the period, Interest	$ 2,008		1,951
Supplementary disclosure of non-cash investing and financing activities:
Embedded derivative on preferred stock issuance			66,227
Notes payable issued in lieu of cash interest payments			918
Redeemable convertible series B preferred stock dividends accrued			750
Accrued fees relating to series B preferred stock issuance			$ 12,250

[1] Balances derived from audited financial statements as of December 31, 2015.